Michael Griffin
Stock Analyst at Citigroup
(2.90)
# 1,538
Out of 4,854 analysts
14
Total ratings
80%
Success rate
21.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JLL Jones Lang LaSalle | Maintains: Neutral | $275 → $240 | $230.06 | +4.32% | 4 | May 28, 2025 | |
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $128.57 | +24.45% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $35.48 | -60.54% | 1 | Mar 4, 2024 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $14.45 | +17.65% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $2.35 | +91.49% | 2 | May 19, 2023 |
Jones Lang LaSalle
May 28, 2025
Maintains: Neutral
Price Target: $275 → $240
Current: $230.06
Upside: +4.32%
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $128.57
Upside: +24.45%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $35.48
Upside: -60.54%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $14.45
Upside: +17.65%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $2.35
Upside: +91.49%